These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12766588)

  • 1. Ductal carcinoma in situ of the breast: impact of pathology on therapeutic decisions.
    Jensen RA; Page DL
    Am J Surg Pathol; 2003 Jun; 27(6):828-31. PubMed ID: 12766588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology and clinical evolution of ductal carcinoma in situ (DCIS) of the breast.
    Page DL; Lagios MD
    Cancer Lett; 1994 Oct; 86(1):1-4. PubMed ID: 7954344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of ductal carcinoma in situ of the breast.
    Schwartz GF; Terribile D
    Obstet Gynecol Clin North Am; 2002 Mar; 29(1):189-200, viii-ix. PubMed ID: 11892866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization.
    Bellamy CO; McDonald C; Salter DM; Chetty U; Anderson TJ
    Hum Pathol; 1993 Jan; 24(1):16-23. PubMed ID: 8380275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actual management of ductal carcinoma in situ of the breast.
    Maass N; Alkasi O; Bauer M; Jonat W; Souchon R; Meinhold-Heerlein I
    Arch Gynecol Obstet; 2009 Nov; 280(5):699-705. PubMed ID: 19259692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the treatment of ductal carcinoma in situ of the breast.
    Baxter NN; Virnig BA; Durham SB; Tuttle TM
    J Natl Cancer Inst; 2004 Mar; 96(6):443-8. PubMed ID: 15026469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
    Mokbel K
    Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ductal carcinoma in situ: a disease entity that merits more recognition.
    Dereere E; Papadimitriou K; Tjalma W; Altintas S
    Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of ductal carcinoma in situ (DCIS). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
    CMAJ; 1998 Feb; 158 Suppl 3():S27-34. PubMed ID: 9484276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
    Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
    Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversies in the Treatment of Ductal Carcinoma in Situ.
    Barrio AV; Van Zee KJ
    Annu Rev Med; 2017 Jan; 68():197-211. PubMed ID: 28099081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.
    Martínez-Pérez C; Turnbull AK; Ekatah GE; Arthur LM; Sims AH; Thomas JS; Dixon JM
    Cancer Treat Rev; 2017 Apr; 55():163-172. PubMed ID: 28402908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of local treatment on the recurrence rate of ductal carcinoma in situ.
    Warneke J; Grossklaus D; Davis J; Stea B; Bebb G; Taylor C; Hastings R; Villar H
    J Am Coll Surg; 1995 Jun; 180(6):683-8. PubMed ID: 7773481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis and management of ductal carcinoma in-situ of the breast.
    Winchester DP; Jeske JM; Goldschmidt RA
    CA Cancer J Clin; 2000; 50(3):184-200. PubMed ID: 10901741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we know what to do when DCIS is diagnosed?
    Sanders ME; Simpson JF
    Oncology (Williston Park); 2011 Aug; 25(9):852-6. PubMed ID: 21936451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions.
    Mardekian SK; Bombonati A; Palazzo JP
    Hum Pathol; 2016 Mar; 49():114-23. PubMed ID: 26826418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
    Pilewskie M; Stempel M; Rosenfeld H; Eaton A; Van Zee KJ; Morrow M
    Ann Surg Oncol; 2016 Oct; 23(11):3487-3493. PubMed ID: 27172775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.